| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 24, 2009Non-GAAP diluted EPS of $0.77 grew 15%; GAAP diluted EPS of $0.78 grew 63%
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 24, 2009-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2010, which ended Oct. 30, 2009. The company...
-
Nov 19, 2009Global Partnership with Vital Images Leverages Advanced Visualization Technology to Streamline Pre-Case Planning through Patient Follow-Up
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 19, 2009-- Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today announced the introduction of an imaging and...
-
Nov 19, 2009
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 19, 2009-- Medtronic, Inc. received today an International Business Leadership Award from the Greater Miami Chamber of Commerce in recognition for its...
-
Nov 19, 2009Company Applauds Leadership of Sens. Dianne Feinstein and Barbara Boxer, Governor Arnold Schwarzenegger, Representative Anna Eshoo and the California Congressional Delegation
MINNEAPOLIS, Nov 19, 2009 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senate's revised proposal regarding...
-
Nov 18, 2009FDA Noted that the Company’s Promised Corrective Actions Appear to be Adequate to Resolve the Issues Raised in the Letter
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 18, 2009-- Medtronic (NYSE: MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the inspection of the...